Protagonist Therapeutics, Inc.

Developing peptide therapeutics across hematology and immune-mediated disease, including rusfertide and icotrokinra.

Back to company catalog

Immunology & hematology · Peptide therapeutics · Commercial partner + late clinical

Compare report options